Evidence map›Paper›PMID 25122681›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

A sequence-specific transcription activator motif and powerful synthetic variants that bind Mediator using a fuzzy protein interface.

Linda Warfield, Lisa M Tuttle, Derek Pacheco, Rachel E Klevit, Steven Hahn

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Commonly asked questions about transcriptional activation domains.Current opinion in structural biology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Ancient transcriptional regulators can easily evolve new pair-wise cooperativity.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  18. Article
  19. Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Linda WarfieldDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and.
Lisa M TuttleDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and Department of Biochemistry, University of Washington, Seattle, WA 98195.
Derek PachecoDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and.
Rachel E KlevitDepartment of Biochemistry, University of Washington, Seattle, WA 98195 klevit@u.washington.edu shahn@fhcrc.org.
Steven HahnDivision of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and klevit@u.washington.edu shahn@fhcrc.org.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Mechanisms of eukaryotic transcription activationR01GM075114 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HAHN, STEVEN M · 2005 to 2020
$7.9M
Structural and Functional Characterization of BRCA1/BARD1R01GM088055 · NIGMS · UNIVERSITY OF WASHINGTON · PI KLEVIT, RACHEL E · 2009 to 2020
$6.5M
NCI NIH HHS P30 CA015704NIGMS NIH HHS R01 GM075114NIGMS NIH HHS R01GM075114NIGMS NIH HHS R01 GM088055NIGMS NIH HHS R01GM088055
6 · The paper itself

Abstract

Although many transcription activators contact the same set of coactivator complexes, the mechanism and specificity of these interactions have been unclear. For example, do intrinsically disordered transcription activation domains (ADs) use sequence-specific motifs, or do ADs of seemingly different sequence have common properties that encode activation function? We find that the central activation domain (cAD) of the yeast activator Gcn4 functions through a short, conserved sequence-specific motif. Optimizing the residues surrounding this short motif by inserting additional hydrophobic residues creates very powerful ADs that bind the Mediator subunit Gal11/Med15 with high affinity via a "fuzzy" protein interface. In contrast to Gcn4, the activity of these synthetic ADs is not strongly dependent on any one residue of the AD, and this redundancy is similar to that of some natural ADs in which few if any sequence-specific residues have been identified. The additional hydrophobic residues in the synthetic ADs likely allow multiple faces of the AD helix to interact with the Gal11 activator-binding domain, effectively forming a fuzzier interface than that of the wild-type cAD.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionBasic-Leucine Zipper Transcription FactorsHydrophobic and Hydrophilic InteractionsKineticsMediator ComplexModels, MolecularMolecular Sequence DataMultiprotein ComplexesMutagenesis, Site-DirectedNuclear Magnetic Resonance, BiomolecularProtein BindingProtein Interaction Domains and MotifsRecombinant ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsBasic-Leucine Zipper Transcription FactorsGAL11 protein, S cerevisiaeGCN4 protein, S cerevisiaeMediator ComplexMultiprotein ComplexesRecombinant ProteinsSaccharomyces cerevisiae ProteinsMediator complexprotein NMR

Identifiers

PMID25122681
PMCPMC4151740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.